Doctors dismissed my symptoms as a sinus infection... a year later I found out I had a deadly brain tumor
She had been practicing for a decade when, in 2014, she noticed mounting fatigue, dizziness, nausea, migraines, and irritability that various doctors chalked up to stress, a hormone imbalance, and a sinus infection. None of them, she felt, truly listened or took her symptoms seriously.
In August 2015, after a year of asking doctors to order her an MRI, one of them finally listened, and what appeared on the scan changed the course of her life entirely.
At the emergency room, doctors informed her that she had a tumor called a meningioma the size of an apple pressing on the left side of her brain so forcefully that both hemispheres were being pushed to the right side of her skull.
While not classified as cancer, meningiomas can be deadly if complications arise, boasting a mortality rate of anywhere from 63 to 90 percent.
She underwent multiple surgeries to seal off the blood vessel feeding the tumor in the hopes of preventing it from growing larger, followed by a procedure to remove the mass in its entirety.
'It's only when I look back in time and think through those appointments and the conversations, and I was at the point where I was begging people to believe me,' Ruhoy told DailyMail.com.
'The sad part is that if someone had believed me earlier on, I think I could have prevented a lot of the recurrences that I had to go through because I've now undergone three rounds of radiation to my brain.'
Ruhoy was healthy before her medical crisis, like many of her current patients. She questioned how this could have happened, feeling she had done everything right.
During her quest for answers, Ruhoy complained of light sensitivity and severe, long-lasting migraines that doctors told her were due to her stressful job as a neurologist in a hospital.
She said one doctor stayed glued to their computer and failed to even make eye contact with her.
Another told her, after she begged for an MRI because she knew something was wrong, that he 'didn't want to feed into the hysteria by ordering an MRI.'
She said 'Looking back, I think that I just wasn't cognizant of what was really happening when it was happening.
'And it's only when I look back in time and think through those appointments and basically I was at the point where I was like begging people to believe me, because things just were getting worse for me.'
Around nine months into her illness, before being diagnosed, she found a primary care doctor and as soon as Ruhoy walked into her new doctor's office, she began to sob, telling the physician that she had reached her wit's end.
'All I said was, please, just order me an MRI. And she said the famous words, "when a neurologist asks you to order a brain MRI, you order a brain MRI,"' Ruhoy said.
'I remember that moment when she just agreed and I almost hugged her. I didn't, I should have, but I was just so grateful, and I will always be grateful.'
Ruhoy still does not know definitively what caused her own tumor.
She said: 'I have a PhD in environmental toxicology, so I've thought long and hard about this; what exposures have I had in my life, what infections have I had in my life.
'Once I was diagnosed, I underwent a big workup, led by myself, to try to answer that exact question, and I really came up with nothing. We don't really know what causes these tumors.'
Inspired by her own journey, Ruhoy would come to specialize in complex post-exposure illnesses (PEIs), such as long Covid and chronic fatigue syndrome.
People with poorly understood chronic illnesses fed by exposure to certain medications, pathogens, or trauma generally describe feeling 'gaslit' by their doctors who don't adequately listen to their concerns, often brush them off as being due to stress, give up trying to treat patients, and alienate them.
She vowed to help patients who have felt let down by the medical establishment and to not allow them to leave her office without setting forth on the path to recovery.
PEIs encompass several diagnoses marked by a wide array of symptoms.
According to Ruhoy, exposure can be to anything external and does not always involve an infection. For instance, she said, long-term exposure to pesticides or mold have been linked to cases of Parkinson's, multiple sclerosis, and chronic fatigue syndrome.
Her newfound career treating PEIs began with Danielle, a dancer in her early 30s who developed debilitating joint pain, food allergies, hives, swelling in her hands and feet, dizziness, headaches, and neck pain.
Many of her patients today are on their fourth or fifth healthcare professional in their quest to figure out what is driving their symptoms.
Danielle was no different.
She asked Danielle a laundry list of questions, questions no doctor had asked her before: Did she ever have any pain disorders? Did family members have similar symptoms to hers? Did she choke a lot? Did she have chest pain?
A detailed blood test revealed Danielle's hypothyroidism, missed by other doctors who hadn't ordered a comprehensive panel.
This likely caused her fatigue, menstrual issues, hair loss, bloating, and skin changes.
Dr Ruhoy addressed each symptom: an MRI uncovered a misdiagnosed spinal problem, treated with muscle relaxants; medication stabilized her dizziness; and specialists managed her heart and joint pain. Within months, Danielle felt significantly better.
In addition to treating patients' symptoms with medication, Ruhoy recommends drug-free treatments: being active, even for a short walk, time in nature, and following a consistent sleep schedule.
'Will you ever be 'normal' again? It's a question I hear often from patients, and unfortunately— if by 'normal' you mean a full return to the person you were before this chronic illness... I can't promise that you will,' Ruhoy wrote in her book Invisible No More.
'However, if you care for yourself, if you remain diligent in the ways we have discussed, and if you attend to your body and listen to the signals it sends you… then you have a great chance of being well. Very well, even.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Guardian
an hour ago
- The Guardian
Wes Streeting ‘thought he had struck deal to halt strike by doctors'
Wes Streeting thought he had struck a deal with resident doctors to stop a five-day strike in England, only for the British Medical Association to then reject it, sources have claimed. The health secretary believed he had secured a verbal agreement with the co-chairs of the BMA's resident doctors committee for a deal that involved progress on tackling five non-pay issues. Whitehall sources say Ross Nieuwoudt and Melissa Ryan decided the agreement made during face-to-face talks last Tuesday was enough for the suspension of the strike, which started on Friday. The deal would have involved resident doctors – formerly junior doctors – getting access to hot meals when working overnight, having some exam fees paid, receiving funding for equipment such as stethoscopes and getting mess rooms and changes to the way their postgraduate training was organised. But when Nieuwoudt and Ryan relayed the potential deal to the full committee, they were told they could not approve it because it did not address the BMA's demand that resident doctors receive a 29% pay rise over the next few years. 'They were told by the committee that they could only talk about pay and none of this soft stuff matters. Wes was furious. They had come incredibly close to a deal,' a source said. Resident doctors in England receive basic pay of between £38,831 and £73,992, with extra payments worth up to 15% of their salaries for working at weekends. The failure to reach a deal underlines the gulf between the BMA and Streeting. He has refused to reopen negotiations over the 5.4% salary increase he has given resident doctors this year. But the union is adamant it will call off industrial action only if he agrees to talk money. The BMA denied that it was responsible for the failure to strike a deal and blamed Streeting. A spokesperson said: 'We cannot be clearer: it was the government that ended the talks. 'Resident doctors do not want to strike. However, we have been compelled to take action because Mr Streeting's ultimatum, which demanded we call off strikes in exchange for nothing more than further talks was simply not acceptable. 'We want to continue our negotiations with Mr Streeting and strongly urge him to get back around the table with a serious proposal, rather than a handful of platitudes.' NHS bosses warn the strikes could 'snowball' and even continue into next year. They fear that nurses, consultant doctors and other NHS staff might stage strikes too. Sir Jim Mackey, the chief executive of NHS England, told the Sunday Times: 'We know that continued disruption over the coming months could see a snowball effect for patients and for staff. 'We've seen that before and it has take a huge effort over the last year to build momentum back up on reducing waiting lists and times.' His deputy, David Probert, who is also chief executive of University College London hospitals trust, told the same paper: 'This could be a marathon. We could be doing this until Christmas or maybe beyond.' The BMA's 55,000 resident doctor members have a legal mandate to take strike action for six months, until 6 January. Kemi Badenoch has pledged to outlaw strikes by doctors, bringing them into line with the police and army, if she becomes prime minister. 'Doctors hold lives in their hands. No one should lose critical healthcare because of strikes but that's what's happening now', the opposition leader posted on X on Sunday. 'That's why a Conservative government led by me would ban doctors' strikes, just like we do the army and police.'
BBC News
an hour ago
- BBC News
Bridgwater £17.8m diagnostic centre to improve access to 'vital scans'
A hospital trust has moved a step forward in its plans to construct a £17.8m diagnostic centre to improve access to vital NHS Foundation Trust has been given approval by NHS England to construct the facility next to Bridgwater Community Hospital. It said it has now applied for planning permission, which if approved could see the facility open next centre will run a range of services including two CT scanners, two MRI scanners, four outpatient rooms and two echocardiography and ultrasound director David Craig said the centre is "expected to provide almost 25,000 additional scans every year". This will enable the centre to provide the Bridgwater population with routine and specialist cardiac and cancer scanning, alongside clinics. It follows the opening of a community diagnostic centre in Taunton in 2020, as well as the development of a diagnostic centre next to Yeovil Hospital, which is expected to open later this year."This development is fantastic news for people in Bridgwater and will improve access to vital healthcare scans, as well as help us to reduce our waiting times," Mr Craig said."The new centre supports one of the three shifts of the NHS 10 Year Plan, which involves transferring care from hospitals into local communities."Running across seven days a week, it will improve access for people in Bridgwater and the surrounding areas to specialist care, with the centre expected to provide almost 25,000 additional scans every year."
The Independent
an hour ago
- The Independent
This fuzzy animal friend may be the key to treating schizophrenia
Llamas – likely without red pajamas – may hold the key to treating schizophrenia. The serious brain disorder causes people to interpret reality abnormally, and affects approximately 3.7 million U.S. adults between the ages of 18 to 65 years old, according to the nonprofit RTI International. But the domesticated South American woolly animal might be be able to help. French researchers said this week that they had used llama antibodies, or proteins that help to protect the immune system, to design a tiny fragment of an antibody known as a 'nanobody' that will trigger a neurotransmitter in the brain involved in regulating neural activity. Neurotransmitters are chemical molecules that carry messages or signals from one nerve cell to the next target cell, according to the Cleveland Clinic. No llamas were harmed in the study and researchers can identify nanobodies in a petri dish. In the past, llama antibodies have also proven effective in fighting Covid and other 'SARS-like' viruses. When scientists at the Institute of Functional Genomics injected the molecule into the veins or the muscles, it was able to break the blood-brain barrier and effectively reach brain receptors. The barrier is a a tightly locked layer of cells that defend your brain from harmful substances. Studying the impact of the nanobodies in two tests using mice, the researchers found that they corrected cognitive deficits that were observed. There was an improvement of cognitive function with just one shot, and a prolonged effect over one week. Clinical studies are now required to show that their findings could be a new avenue of treatment for schizophrenia. "In humans obviously we don't know [yet], but in mice yes, it is sufficient to treat most deficits of schizophrenia," molecular biologist Jean-Philippe Pin told Newsweek.. He was a co-author of the research which was published in the journal Nature. Pin said that medications currently given to schizophrenia patients "treat the symptoms well, but less the cognitive deficits." The cause of the chronic condition remains unknown, but the World Health Organization says it is thought that an interaction between genes and a range of environmental factors may be the reason. The exact prevalence of schizophrenia is difficult to measure. Some have tied cases in Canada to cannabis use. Although schizophrenia can occur at any age, people are typically diagnosed between the ages of 16 and 30. Symptoms vary from person to person. There is no cure, but it can be treated through antipsychotic medications, talk therapy, and self-management strategies, the National Alliance on Mental Illness says. The study's authors hope to add this strategy to the list. 'This research confirms the potential of nanobodies as a new therapeutic strategy for acting on the brain, with their use eventually being broadened to include the treatment of other neurological illnesses,' the institute said in a statement.
